전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,399 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

ADCLimited DatastaleADC TherapeuticsPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#antibody-drug-conjugate#DiffuseLargeB-CellLymphoma+2
Trials 48Status Recruiting
AntibodyLimited DatastaleEpizyme, Inc.Phase 2

Tafasitamab (Tafasitamab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#RelapsedHematologicMalignancy+3
Trials 48Status Discontinued
CGTLimited DatastaleSun Yat-sen UniversityPhase 2

Relmacabtagene Autoleucel (Autoleucel, Autoleucel (Relmacabtagene Autoleucel))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · Large B Cell Diffuse Lymphoma

#LargeBCellDiffuseLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 47Status Recruiting
CGTLimited DatastaleShenzhen Hornetcorn Bio-technol…Phase 1

Autologous NK cell therapy (Autologous NK cell therapy)

NK Cell Mediated Immunity; Endometriosis · NK Cell Mediated Immunity

#NKCellMediatedImmunity#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 47Status Active
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

Penpulimab (Penpulimab)

Advanced Malignant Neoplasm · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedMalignantNeoplasm+2
Trials 47Status Active
CGTLimited DatastalePoseida Therapeutics, Inc.Phase 2

autologous anti-BCMA chimeric antigen receptor T cells (autologous anti-BCMA chimeric antigen receptor T cells)

ITP · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 47Status Active
ADCLimited DatastaleAstellasPhase 3

EV/P (enfortumab vedotin and pembrolizumab, enfortumab vedotin and pembrolizumab (EV/P))

Advanced Bladder Cancer · Advanced Bladder Cancer

#AdvancedBladderCancer#ADC#Phase3#antibody-drug-conjugate#ADCsandimmunotherapyhavechangedt+1
Trials 47Status Recruiting
CGTLimited DatastaleVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 46Status Recruiting
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleFondazione Policlinico Universi…Preclinical

Cell function identification (Cell function identification)

Bronchiolitis Obliterans Syndrome (BOS) · Bronchiolitis Obliterans Syndrome (BOS)

#BronchiolitisObliteransSyndromeB#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 46Status Discontinued
CGTLimited DatastaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Recruiting
AntibodyLimited DatastaleImmunityBio, Inc.Phase 2

NAI (Nogapendekin Alfa-Inbakicept, Nogapendekin Alfa-Inbakicept (NAI))

Acute Respiratory Distress Syndrome; Severe Community-Acquired Pneum · Acute Respiratory Distress Syndrome

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#monoclonal-antibody#SevereCommunity-AcquiredPneum+2
Trials 46Status Discontinued
CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Active
CGTLimited DatastaleHistograft Co., Ltd.Preclinical

"Histograft", a bone substitute based on octacalcium phosphate (OCP, "Histograft", a bone substitute based on octacalcium phosphate, "Histograft", a bone substitute based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA gene)

Non Union Fracture; Non-Union of Ankle Joint Without Infection · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 45Status Active
AntibodyLimited DatastaleGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#ResectableColorectalCarcinoma+1
Trials 45Status Recruiting
CGTLimited DatastaleAcrotech Biopharma Inc.Phase 1

Belinostat (Belinostat)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Discontinued
CGTLimited DatastaleSecuraBioPhase 1

Duvelisib (Duvelisib)

Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Active
AntibodyLimited DatastaleIndiana Hemophilia &Thrombosis …Approved

Emicizumab (Emicizumab)

Haemophilic Pseudotumour · Factor VIII Deficiency, Congenital

#FactorVIIIDeficiencyCongenital#Antibody#Approved#monoclonal-antibody#HaemophilicPseudotumour+2
Trials 45Status Discontinued
CGTLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Letermovir (Letermovir)

Cell Therapy · Cell Therapy

#CellTherapy#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 45Status Recruiting

13 / 120 pages

← PreviousNext →